Últimas noticias sobre Warner Music Gr (NASDAQ:WMG) Bolsa

WARNER MUSIC GROUP CORP-CL A

Warner Music Gr

Warner Music is the third-largest of the three major record companies. Recorded music accounts for most of the firm's revenue, with the segment housing notable record labels including Atlantic Records, Warner Records, Elektra Records. Some of the most successful current artists signed to record deals with Warner include Ed Sheeran, Bruno Mars, Cardi B, and Dua Lipa. Warner's remaining revenue comes from its publishing business, where Warner Chappell represents more than 180,000 songwriters and composers, some of whom are also Warner recording artists but many of whom are not recording artists or are attached to other labels. Warner Chappell controls more than 1 million musical compositions. Access Industries controls 98% of Warner's voting rights, while holding a 72% economic interest.

July,16,,2021,,Brazil.,In,This,Photo,Illustration,The,Spotify

Analyst Color

GOOG

GOOGL

NTES

SIRI

Sony Group Corporation American Depositary Shares

SONY

SPOT

Spotify sube tras un informe de Goldman Sachs que prevé el crecimiento del streaming musical y nuevas oportunidades de monetización.

Spotify sube tras informe de Goldman Sachs que prevé gran expansión del mercado musical global

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

DELL

NFLX

SWKS

Descubre las recientes ventas de insiders en Skyworks, Dell, Warner Music y Netflix, y cómo podrían influir en el mercado.

Netflix, Dell y otras 2 acciones que los insiders están vendiendo

Media

Sony negocia la compra del catálogo musical de Pink Floyd por $500M, incluyendo éxitos como &#34;Money&#34; y &#34;Another Brick in the Wall&#34;.

Sony busca adquirir los derechos musicales de Pink Floyd por $500M

Warner Music Group Corp. - Class A Common Stock

Warner Music Group Corp

WELLNESS MATRIX GRP INC by Wellness Matrix Group, Inc.

Wellness Matrix Group Inc

Wilmington PLC

WIIM

BRCC

BRC shares are trading lower after the company announced it has priced a $35 million public offering of common stock.

ACTU

Actuate Therapeutics Initiates Planning Of Phase 2 Trial Of Elraglusib In Children, Adolescents, And Adults With Refractory/Resistant Ewing Sarcoma

HYPR

Hyperfine shares are trading higher after the company announced the first commercial sales of its Swoop system, powered by Optive AI software.

Actuate Therapeutics Announces End Of Phase 1 Portion Of Clinical Study Evaluating Elraglusib Monotherapy Or In Combination With Irinotecan, Irinotecan Plus Temozolomide, Or With Cyclophosphamide Plus Topotecan In Pediatric Patients With Refractory Malignancies

Offerings

NioCorp Prices $45.0M Public Offering Of 13,850,000 Shares At $3.25/Share

Guidance

IQST

IQSTEL Jun. Revenue $27.3M, Up From $23.7M In May; Reports Prelim. 1H Revenue Of $128.8M

Swiss pharmaceutical giant Novartis AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVS#NYSE">NVS</a>) reported second-quarter 2025 earnings on Thursday and raised its full-year earnings forecast.
Quarterly sales reached $14.05 billion, almost in line with the analysts&#8217; consensus <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">estimate of $14.06 billion</a>.
Net sales <a target="_blank" href="https://www.novartis.com/news/media-releases/novartis-reports-strong-q2-double-digit-sales-growth-and-core-margin-expansion-raises-fy-2025-core-operating-income-guidance" rel="noreferrer noopener">grew</a> 12% year over year (+11% on constant currency or cc) with core operating income up 20% to $5.93 billion (+21% on constant currency).
Also Read: <a target="_blank" href="https://www.benzinga.com/news/health-care/25/07/46292859/novartis-gets-swiss-approval-for-first-malaria-drug-for-babies" rel="noreferrer noopener">Novartis Gets Swiss Approval For First Malaria Drug For Babies</a>
Sales growth driven by performance from breast cancer treatment, Kisqali ($1.18 billion, +64% cc), Entresto ($2.36 billion, +22% cc), multiple sclerosis drug, Kesimpta ($1.08 billion, +33% cc), Scemblix ($298 million, +79% cc), Leqvio ($298 million, +61% cc), and Pluvicto ($454 million, +30% cc).
Novartis reported adjusted earnings of $2.42 per share, beating the consensus of $2.38.
The company also announced a substantial share buyback program. Novartis said it is initiating a share buyback of up $10 billion to be completed by year-end 2027.
&#8220;Our robust balance sheet and confidence in our mid- and long-term growth enable us to initiate an up-to $10 billion share buyback as part of our commitment to balanced capital allocation,&#8221; stated CEO Vas Narasimhan in a statement on Thursday.
Earlier in July, Novartis released topline results from the Phase 3 GCAptAIN study evaluating Cosentyx (secukinumab) for newly diagnosed or relapsing <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">giant cell arteritis (GCA)</a>.
The study evaluated Cosentyx with a 26-week steroid taper and compared it to a placebo plus a 52-week steroid taper.&nbsp;Cosentyx did not demonstrate a statistically significant improvement in sustained remission at <a target="_blank" href="https://www.benzinga.com/news/health-care/25/07/46243947/novartis-cosentyx-fails-late-stage-giant-cell-arteritis-trial" rel="noreferrer noopener">Week 52 compared to placebo</a>.
<h2 class="wp-block-heading">Outlook</h2>
For fiscal year 2025, Novartis reaffirms that net sales will grow in the high single digits. 2025 core operating income is expected to grow in the low teens, compared to the low double <a target="_blank" href="https://www.benzinga.com/25/04/45075714/novartis-q1-earnings-beat-street-view-ceo-confident-to-deliver-upgraded-2025-guidance" rel="noreferrer noopener">digits forecasted earlier</a>.
&#8220;We continue to assume Entresto US generic entry in mid-2025 for forecasting purposes, though the timing of generic entry is subject to ongoing IP and regulatory litigation,&#8221; Novartis said in the release.
<h2 class="wp-block-heading">Management Update</h2>
In a separate announcement, Novartis provided a key leadership update: Chief Financial Officer Harry Kirsch will <a target="_blank" href="https://www.novartis.com/news/media-releases/novartis-appoints-mukul-mehta-chief-financial-officer-harry-kirsch-retires-after-22-years-company" rel="noreferrer noopener">retire</a> in March 2026, concluding an impressive 22-year tenure at the company, including 12 years in the CFO role since 2013.
He will be succeeded by Mukul Mehta, who currently serves as the company&#8217;s head of business planning and analysis, digital finance, and tax.
Price Action: NVS stock is trading lower by 1.71% to $116.35 during the premarket session at last check Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46463670/supermicro-launches-new-ai-servers-with-intel-xeon-6-chips" target="_blank" rel="noreferrer noopener">Supermicro Launches New AI Servers With Intel Xeon 6 Chips</a></li>
</ul>
Photo via Shutterstock

Biotech

Earnings

Large Cap

Health Care

Buybacks

Management

Movers

General

Novartis Trims Operating Income Outlook After Strong Q2 Performance, Initiates $10 Billion Stock Buyback

Nano Labs shares are trading higher after the company announced it has appointed a new CEO to lead the global crypto reserve strategy of its subsidiary.

Morgan Stanley analyst Kristine Liwag maintains Teledyne Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDY#NYSE">TDY</a>) with a Equal-Weight and raises the price target from $535 to $580.

Price Target

Analyst Ratings

Morgan Stanley Maintains Equal-Weight on Teledyne Technologies, Raises Price Target to $580

ATHR

Aether Holdings' Alpha Edge Media Acquires Digital Asset Research And Publication, AltcoinInvesting.co

BPMC

Trading Halt: Halt status updated at 8:45:00 AM ET: Quotation Resumption: News and Resumption Times

Morgan Stanley analyst Kristine Liwag maintains Curtiss-Wright (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CW#NYSE">CW</a>) with a Overweight and raises the price target from $405 to $550.

Morgan Stanley Maintains Overweight on Curtiss-Wright, Raises Price Target to $550

Stock Split

LCID

Lucid Files Preliminary Proxy Statement To Initiate Plan For 1-for-10 Reverse Stock Split

NUWE

Nuwellis shares are trading lower after the company announced it has terminated its REVERSE-HF clinical trial to prioritize resources and redirect investment.

INSE

Inspired Entertainment Expands Long-Term Partnership With William Hill To Deliver Comprehensive Upgrade To William Hill's Virtual Sports Offering Across Its UK Retail Estate

OKLO

Oklo shares are trading higher after the company completed the U.S. Nuclear Regulatory Commission's pre-application readiness assessment for Phase 1 of its combined license application for the Aurora Powerhouse.

Stifel analyst Jeffrey Stantial maintains Monarch Casino &amp; Resort (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCRI#NASDAQ">MCRI</a>) with a Hold and raises the price target from $81 to $92.

MCRI

Stifel Maintains Hold on Monarch Casino & Resort, Raises Price Target to $92

B. Riley Securities analyst Mike Crawford maintains TTM Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTMI#NASDAQ">TTMI</a>) with a Buy and raises the price target from $36 to $50.

TTMI

B. Riley Securities Maintains Buy on TTM Technologies, Raises Price Target to $50

BTCT

BTC Digital Announces Transformative, Strategic Shift To Fully Embrace Ethereum As Core Asset And Operational Foundation; Closes $6M Financing Round, Adds New $1M ETH Position

Truist Securities analyst Matthew Coad maintains Affirm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) with a Buy and raises the price target from $58 to $72.

AFRM

Truist Securities Maintains Buy on Affirm Holdings, Raises Price Target to $72

Press Releases

Warner Music Group Corp. to Participate in Morgan Stanley Technology, Media & Telecom Conference

Entertainment

WARNER MUSIC GROUP AND JOSH GROBAN HONORED AT HARMONY PROGRAM GALA

Warner Music Group Corp. to Conduct Earnings Conference Call on Thursday, May 8, 2025

WARNER MUSIC GROUP APPOINTS ARMIN ZERZA AS EVP & CFO EFFECTIVE MAY 5

WARNER MUSIC GROUP PARTNERS WITH ENTREPRENEURIAL POWERHOUSE ANJULA ACHARIA

Warner Music Group Corp. Reports Results for Fiscal Second Quarter Ended March 31, 2025

Dividends

Warner Music Group Corp. Announces Quarterly Cash Dividend

COLDPLAY TO RE-RELEASE ALBUMS ON ECORECORDS MADE FROM PLASTIC BOTTLES

WARNER MUSIC GROUP AND BAIN CAPITAL ANNOUNCE LAUNCH OF JOINT VENTURE TO INVEST UP TO $1.2 BILLION IN ICONIC MUSIC CATALOGS

Warner Music Group Corp. to Conduct Earnings Conference Call on Thursday, August 7, 2025

AMC Entertainment Holdings, Inc. Class A Common Stock

AMC Entertainment Hldgs

Atlanta Braves Holdings, Inc. - Series A Common Stock

Atlanta Braves Holdings

Atlanta Braves Holdings, Inc. - Series C Common Stock

Cinemark Holdings Inc Cinemark Holdings, Inc. Common Stock

Cinemark Holdings

Walt Disney

Liberty Media Corporation - Series A Liberty Formula One Common Stock

Liberty Media

Ordinary Shares (New Liberty Formula One) Series A

Liberty Media Corporation - Series C Liberty Formula One Common Stock

Ordinary Shares (New Liberty Formula One) Series C

iQIYI

K Wave Media

Lionsgate Studios

Liberty Media Corporation - Series A Liberty Live Common Stock

Liberty Live

Ordinary Shares (New Liberty Live) Series A

Liberty Media Corporation - Series C Liberty Live Common Stock

Ordinary Shares (New Liberty Live) Series C

Live Nation Entertainment, Inc. Common Stock

Live Nation Entertainment

Manchester United Ltd. Class A Ordinary Shares

Manchester United

Marcus

Madison Square Garden Entertainment Corp. Class A Common Stock

Madison Square Garden

Madison Square Garden Sports Corp. Class A Common Stock (New)

Netflix

Roku

Reservoir Media

Sphere Entertainment Co. Class A Common Stock

Sphere Entertainment

Starz Entertainment Corp. - Common Shares

Starz Entertainment

TKO Group Holdings, Inc. Class A Common Stock

TKO Group Holdings

Tencent Music Entertainment Group American Depositary Shares, each representing two Class A Ordinary Shares

Comments

Warner Music Gr

Noticias

Últimas noticias sobre Warner Music Gr (NASDAQ:WMG) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL